Blueblood Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve Blueblood Ventures Limited ....
Awaiting price reaction for this filing.
Blueblood Ventures Ltd has informed BSE that its Board of Directors will meet on Friday, 14 November 2025 at its registered office in Greater Kailash-II, New Delhi. The main agenda is to consider and approve the Unaudited Standalone Financial Results for the second quarter and half year ended 30 September 2025. The company also reminded that the trading window for designated persons and insiders has been closed since 30 September 2025 and will reopen on 16 November 2025, in line with insider trading norms.
This is a routine advance notice with no actual financial numbers disclosed yet. Shareholders should watch for the Q2/H1 FY26 results announcement after 14 November, which may move the stock depending on the performance reported.